“Pace of money flowing into early-stage has accelerated… even post-COVID”

The EV segment in India is charged up and Chiratae Ventures’ Karan Mohla tells us which way the road is turning 

Asha Menon - January 01, 2021

Selling prescription drugs can be a pain. Doceree offers an easy way out

The pharma-marketing start-up has patented tech to reach the right message to the right doctor 

Debangana Ghosh - November 04, 2020

“People often talk about PMF or product-market fit. We call it as pandemic-market fit”

The pandemic has filtered out the second-bests in early-stage, according to Lightspeed India Partners’ Hemant Mohapatra 

Asha Menon - December 04, 2020

“I do not take the market’s view as gospel truth, but I also do not assume it is foolish or stupid”

ASK Group’s Bharat Shah on why the market is his guidepost when it comes to deciphering tangible price and intangible value

N Mahalakshmi - October 17, 2020

What’s happening at Coforge is more than just a name change

CEO Sudhir Singh believes his new team and an aggressive incentive structure could soon take the company to the billion-dollar mark 

V Keshavdev - September 30, 2020

Building a future-ready, innovative healthcare industry

India’s scientific excellence provides us the opportunity to achieve self-reliance in pharmaceuticals, biopharma and holistic care

Kiran Mazumdar-Shaw - August 28, 2020

Tata Elxsi is steering away from the automotive lane to remain on the growth track

The overshadowed Tata company is proving its worth with swift and smart detours 

Meenakshi Radhakrishnan-Swami - July 30, 2020

Why Ashish Kacholia, Mukul Agrawal and Kedaara Capital are hot on Religare Enterprises

Despite its troubled past, its healthcare insurance business may turn out to be a dark horse 

Anishaa Kumar - July 16, 2020

Is there more upside in store for pharma stocks?

Over the past year, the Nifty Pharma Index has gained 23% while the Nifty has declined by 11% 

June 30, 2020